z-logo
open-access-imgOpen Access
Issues of Medical Products Import Phase-out Applied in the Field of Traumatology and Orthopaedics of the Republic of Kazakhstan. Policy Brief
Author(s) -
Olzhas Bekarissov,
Arman Batpen,
Kuanysh Ospanov,
Galiya Orazova
Publication year - 2021
Publication title -
research institute of traumatology and orthopedics
Language(s) - English
Resource type - Journals
ISSN - 1684-9280
DOI - 10.52889/1684-9280-2021-1-56-4-11
Subject(s) - traumatology , field (mathematics) , medicine , orthopedic surgery , phase (matter) , production (economics) , business , economics , surgery , chemistry , mathematics , organic chemistry , pure mathematics , macroeconomics
What the problem is? - Medical products applied in the field of traumatology and orthopaedics of Kazakhstan are fully import phase-out; - Measures carried out within the framework of medical products import phase-out applied in this field have been put on hold due to lack of funding. Policy options • Option 1. Regulatory and economic support from the state in particular an assistance in investors attracting for production growth of the domestic medical products applied in the field of traumatology and orthopaedics; • Option 2. Upgrade training of participants of the process on medical products import phase-out applied in the field of traumatology and orthopaedics of Kazakhstan for promotion of competitiveness on the market; • Option 3. Development of longstanding complex research and practice program for formation of clinical evidential base on efficiency and safety of medical products the manufacturing of which is planned within the framework of import phase-out policy. Policy options realization perspective Our three policy options are mutually supportive. The combined realization of these policy options will allow organizing the production of domestic medical products in the field of traumatology and orthopaedics with the aim of import phase-out. Conclusions Import phase-out of medical products in the field of traumatology and orthopaedics (prostheses, implants, various plates, etc.), of course, is an effective solution in terms of economics. However, to achieve this goal from the state, regulatory and economic support is needed. In turn, the manufacturer must also increase its own potential. We expect that after the stabilization of domestic production of medical products in traumatology orthopaedics and full-fledged import phase-out, problems associated with the export of these products may arise. We believe that a “vertical” strategy focused on the domestic market is most suitable for the development of domestic production of medical products. Key words: traumatology and orthopaedics, medical products, import phase-out, Kazakhstan

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom